Asthma

National Jewish Health is at the forefront of asthma research, investigating the fundamental mechanisms that drive the disease. Our research aims to identify new therapeutic targets and biomarkers that can help predict disease progression and personalize treatment. By focusing on both the immune system’s role in asthma and the environmental triggers that exacerbate symptoms, our researchers are developing more precise, individualized treatment strategies to improve asthma control and enhance the quality of life for patients. We emphasize patient-centered care, integrating the latest findings into clinical practice to ensure treatments are tailored to each patient’s unique asthma profile. Here is an overview of our research efforts in this area:

• Cohen Asthma Institute:  Our institute focuses on comprehensive asthma care, integrating both clinical and research components. We work to understand the underlying mechanisms of asthma, develop new treatments and improve patient outcomes.
• Research Programs: Our cutting-edge research in asthma explores the genetic, environmental and immunological factors that contribute to the disease. We conduct clinical trials and research studies aimed at better understanding disease mechanisms and testing new therapies.
• Collaborative Studies: We frequently collaborate with other institutions and researchers to expand the scope and impact of our asthma research. This includes national and international studies aimed at improving asthma management and treatment.
• Murnick Asthma Discovery Accelerator Program
• Innovative Therapies: Research at National Jewish Health involves the development of novel therapies and treatments, ranging from new medications to advanced biologic therapies targeting specific pathways involved in asthma.
• Patient-Centered Research: We focus on research that directly impacts patient care throughout the lifespan, such as developing improved diagnostic tools, refining methods for monitoring asthma and enhancing personalized treatment approaches.
• Asthma Research Advancements: Novel antimicrobial treatment for nocturnal asthma.
  Discovery of IgE, major protein involved in allergic reactions and eosinophilic asthma.